APA

Mileski W. J., Burkhart D., Hunt J. L., Kagan R. J., Saffle J. R., Herndon D. N., Heimbach D. M., Luterman A., Yurt R. W., Goodwin C. W. & Hansborough J. (20030619). Clinical effects of inhibiting leukocyte adhesion with monoclonal antibody to intercellular adhesion molecule-1 (enlimomab) in the treatment of partial-thickness burn injury. : The Journal of trauma.

Chicago

Mileski William J, Burkhart Deborah, Hunt John L, Kagan Richard J, Saffle Jeffrey R, Herndon David N, Heimbach David M, Luterman Arnold, Yurt Roger W, Goodwin Cleon W and Hansborough John. 20030619. Clinical effects of inhibiting leukocyte adhesion with monoclonal antibody to intercellular adhesion molecule-1 (enlimomab) in the treatment of partial-thickness burn injury. : The Journal of trauma.

Harvard

Mileski W. J., Burkhart D., Hunt J. L., Kagan R. J., Saffle J. R., Herndon D. N., Heimbach D. M., Luterman A., Yurt R. W., Goodwin C. W. and Hansborough J. (20030619). Clinical effects of inhibiting leukocyte adhesion with monoclonal antibody to intercellular adhesion molecule-1 (enlimomab) in the treatment of partial-thickness burn injury. : The Journal of trauma.

MLA

Mileski William J, Burkhart Deborah, Hunt John L, Kagan Richard J, Saffle Jeffrey R, Herndon David N, Heimbach David M, Luterman Arnold, Yurt Roger W, Goodwin Cleon W and Hansborough John. Clinical effects of inhibiting leukocyte adhesion with monoclonal antibody to intercellular adhesion molecule-1 (enlimomab) in the treatment of partial-thickness burn injury. : The Journal of trauma. 20030619.